U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™

Conditions

• Acne Vulgaris

Interventions

• OTHER: MAXCLARITY II (2.5% BPO) Foam Cleanser
• OTHER: MAXCLARITY II (2.5% BPO) Foam Treatment
• OTHER: MAXCLARITY II (0.5% Salicylic Acid) Toner Foam
• OTHER: PROACTIV (2.5% BPO) Renewing Cleanser
• OTHER: PROACTIV (2.5% BPO) Repairing Lotion
• OTHER: PROACTIV (2.5% BPO) Revitalizing Toner

Sponsor

Stiefel, a GSK Company